RT Book, Section
A1 Dirkx, Tonja C.
A1 Woodell, Tyler B.
A2 Papadakis, Maxine A.
A2 McPhee, Stephen J.
A2 Rabow, Michael W.
A2 McQuaid, Kenneth R.
SR Print(0)
ID 1193126657
T1 Kidney Biopsy
T2 Current Medical Diagnosis & Treatment 2023
YR 2023
FD 2023
PB McGraw-Hill Education
PP New York, NY
SN 9781264687343
LK accessmedicine.mhmedical.com/content.aspx?aid=1193126657
RD 2024/04/19
AB Indications  for  percutaneous  needle  biopsy  include  (1)  unexplained  decline  in  GFR;  (2)  unexplained  proteinuria  or  hematuria,  or  both;  (3)  previously  identified  and  treated  lesions  to  guide  future  therapy;  (4)  systemic  diseases  associated  with  kidney  dysfunction,  such  as  SLE,  anti-GBM  disease,  and  granulomatosis  with  polyangiitis  (eFigure  22–3);  and  (5)  kidney  transplant  dysfunction,  to  evaluate  for  transplant  rejection  or  other  abnormalities.  Kidney  biopsies  should  only  be  performed  if  the  results  will  influence  the  treatment  plan  or  facilitate  discussion  about  prognosis.  Relative  contraindications  include  a  solitary  or  ectopic  kidney  (exception  for  transplant  allografts),  horseshoe  kidney,  ESKD,  congenital  anomalies,  and  multiple  cysts.  Absolute  contraindications  include  an  uncorrected  bleeding  disorder;  severe  uncontrolled  hypertension;  renal  infection  or  neoplasm;  hydronephrosis;  or  uncooperative  patients,  including  those  who  are  unable  to  lie  flat  for  the  procedure.